Quick Takeaways
- ELI LILLY & Co has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $135,446,834.
- Recent insider filing activity is available below.
Insider Trading & Ownership of ELI LILLY & Co
- Location
- Indianapolis, IN
- Summary
- The estimated value of insider holdings of ELI LILLY & Co is at least $135,446,834 dollars as of 15 Jan 2026. ELI LILLY & Co is the 10%+ Owner of Aktis Oncology, Inc. and owns shares of Aktis Oncology, Inc. (AKTS) stock worth about $135.45M.
- Signature
- /s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow ELI LILLY & Co and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Aktis Oncology, Inc. ($135,446,834).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of ELI LILLY & Co
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 10%+ Owner | $135,446,834 | 12 Jan 2026 | ||
| SGTX | Sigilon Therapeutics, Inc. | 10%+ Owner | 11 Aug 2023 |
Insider Transactions Reported by ELI LILLY & Co:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.